IP Verse

Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna

Patent No. EP3054993 (titled "Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna") was filed by Eberhard Karls Universitt Tbingen Medizinische Fakultt on Oct 6, 2014. The application was issued on Dec 4, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBSep 3, 2020WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3054993

EBERHARD KARLS UNIVERSITT TBINGEN MEDIZINISCHE FAKULTT
Application Number
EP14781175A
Filing Date
Oct 6, 2014
Status
Revoked
Jan 14, 2022
Publication Date
Dec 4, 2019
External Links
Slate, Register , Google Patents